Laboratory Historical Income Statement
| LH Stock | USD 242.15 0.00 0.00% |
Historical analysis of Laboratory income statement accounts such as Operating Income of 820.1 M, EBIT of 845.9 M or Ebitda of 1.1 B can show how well Laboratory of performed in making a profits. Evaluating Laboratory income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Laboratory's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Laboratory latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Laboratory is a good buy for the upcoming year.
Laboratory |
About Laboratory Income Statement Analysis
Laboratory Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Laboratory shareholders. The income statement also shows Laboratory investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Laboratory Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Total Revenue
Total revenue comprises all receipts Laboratory generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Laboratory of minus its cost of goods sold. It is profit before Laboratory operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Operating Income
Operating Income is the amount of profit realized from Laboratory operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Laboratory of is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Laboratory's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, Laboratory's EBIT is increasing as compared to previous years. The Laboratory's current Depreciation And Amortization is estimated to increase to about 606.2 M, while Gross Profit is projected to decrease to under 2 B.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 5.6B | 4.4B | 3.4B | 2.0B | Total Revenue | 16.1B | 14.9B | 12.2B | 12.8B |
Laboratory income statement Correlations
Click cells to compare fundamentals
Laboratory Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Laboratory income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 240.7M | 207.4M | 212.1M | 180.3M | 199.6M | 209.6M | |
| Total Revenue | 11.6B | 14.0B | 16.1B | 14.9B | 12.2B | 12.8B | |
| Gross Profit | 3.3B | 5.0B | 5.6B | 4.4B | 3.4B | 2.0B | |
| Operating Income | 1.3B | 2.4B | 3.3B | 1.8B | 725.6M | 820.1M | |
| Ebit | 1.3B | 2.4B | 3.3B | 1.4B | 768.5M | 845.9M | |
| Ebitda | 2.0B | 3.3B | 4.3B | 2.0B | 1.3B | 1.1B | |
| Depreciation And Amortization | 638.4M | 825M | 940M | 537.2M | 577.3M | 606.2M | |
| Other Operating Expenses | 10.2B | 11.0B | 12.8B | 12.7B | 11.4B | 12.0B | |
| Cost Of Revenue | 8.3B | 9.0B | 10.5B | 10.5B | 8.8B | 9.2B | |
| Total Operating Expenses | 1.9B | 2.0B | 2.3B | 2.3B | 2.0B | 1.1B | |
| Income Before Tax | 1.1B | 2.2B | 3.1B | 1.6B | 568.9M | 748.7M | |
| Total Other Income Expense Net | (225.3M) | (226.3M) | (132.9M) | (199.1M) | (156.7M) | (148.9M) | |
| Net Income | 823.8M | 1.6B | 2.4B | 1.3B | 418M | 513.9M | |
| Income Tax Expense | 280M | 662.1M | 747.1M | 302M | 188.5M | 233.9M | |
| Selling General Administrative | 1.6B | 1.7B | 2.0B | 2.0B | 2.2B | 1.1B | |
| Net Income Applicable To Common Shares | 823.8M | (900K) | 2.4B | 1.3B | 1.5B | 1.5B | |
| Minority Interest | 20.1M | 20.7M | (2.2M) | (1.5M) | (1.2M) | (1.1M) | |
| Net Income From Continuing Ops | 824.9M | (900K) | 2.4B | 1.3B | 861.4M | 880.6M | |
| Tax Provision | 280M | 662.1M | 747.1M | 302M | 210M | 379.6M | |
| Interest Income | 212.3M | 194.2M | 175.4M | 166M | 149.4M | 166.7M | |
| Net Interest Income | (240.7M) | (207.4M) | (212.1M) | (180.3M) | (200.4M) | (210.4M) | |
| Reconciled Depreciation | 577.2M | 624.7M | 745.1M | 633.9M | 658M | 679.5M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.28 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.